CAS:134861-34-0:GE 2270A

Send Inquiry
CAS:134861-34-0:GE 2270A
Details
CAS: 134861-34-0
Core structure: Natural thiopeptide cyclic peptide antibiotic with multiple thiazole/oxazole heterocycles and rigid macrocyclic peptide backbone
We also provide specifications from crude to 99% purity, please contact us for details!
Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Polypeptide Antibiotic / Protein Synthesis Inhibitor Thiopeptide Antibiotic
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas:134861-34-0:ge 2270a in China, also supports custom service. Welcome to wholesale bulk high quality cas:134861-34-0:ge 2270a from our factory. Contact us for more details.

 

Product Name CAS:134861-34-0:GE 2270A
Description GE 2270A is a novel thiopeptide antibiotic produced by rare Actinomycetes fermentation. It specifically binds to bacterial elongation factor EF-Tu and blocks the protein synthesis elongation process. It exhibits potent antibacterial activity against multidrug-resistant Gram-positive bacteria such as MRSA and VRE. Applied in drug-resistant infection, antibacterial mechanism research and novel antibiotic development.
Peptide Purity (HPLC, %) 90%/95%/98%
Molecular Formula C₅₄H₄₆N₁₂O₁₀S₆
Molecular Weight (Da) ~1191.42
Structure type Polyheterocyclic thiopeptide cyclic peptide antibiotic

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Full Amino Acid Sequence Molecular Formula Exact Mass (Da) Average MW (Da) Cyclization Mode Structure Type
GE 2270A GE2270A; Thiopeptide antibiotic; EF-Tu inhibitor; CAS 134861-34-0 Anti-multidrug-resistant bacteria,Protein synthesis inhibition,EF-Tu targeting,MRSA/VRE activity,Thiopeptide cyclic peptide,Novel antibiotic development Macrocyclic peptide backbone embedded with multiple thiazole/oxazole heterocycles, rigid conjugated structure C₅₄H₄₆N₁₂O₁₀S₆ 1190.21 1191.42 Peptide bond + heterocycle macrocyclization Non-ribosomal thiopeptide antibiotic

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-GE27001 Pale yellow to yellow amorphous powder Store at -20℃, strictly protected from light, sealed and dry, aliquoted; avoid high temperature and acid/base Solid powder stable for 2 years at 2-8℃ sealed and dry; stock solutions prepared in DMSO or chloroform Stable for 72 h at 4℃ under anhydrous & dark conditions. Prone to precipitation in aqueous phase; **aqueous solution extremely unstable, must be prepared freshly before use**. **Extremely poor water solubility, organic solvents such as DMSO required**. Heterocycles prone to ring-opening degradation under acid/base and high temperature Stable for 2 years at -20℃ under dry & dark conditions

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-GE27001 Thiopeptide cyclic peptide antibiotic that targets EF-Tu to block bacterial protein synthesis, potent against multidrug-resistant Gram-positive bacteria GE 2270A is a typical thiazolyl thiopeptide natural product produced via non-ribosomal peptide synthesis pathway, with a highly rigid macrocyclic conjugated structure. It specifically binds to the GTPase domain of bacterial elongation factor EF-Tu, inhibits the GTP hydrolysis activity of EF-Tu, and blocks the transport of aminoacyl-tRNA to the ribosomal A site, thereby inhibiting the elongation phase of bacterial protein synthesis and ultimately leading to bacterial growth arrest and death. This molecule exhibits nanomolar antibacterial activity against Gram-positive bacteria such as Staphylococcus aureus, Streptococcus and Enterococcus, and is also effective against clinical drug-resistant strains such as MRSA and VRE, with no cross-resistance to existing antibiotics. It serves as a core tool compound for drug-resistant infection research, novel antibiotic target validation, and thiopeptide SAR analysis. Drug-resistant infection research,Novel antibiotic development,Bacterial protein synthesis mechanism,Ribosome function study,MRSA/VRE research,Microbial pharmacology study Bacterial elongation factor EF-Tu; Protein synthesis elongation blockade pathway; Gram-positive bacteria growth inhibition pathway

 

 

 

 

 

 

Hot Tags: cas:134861-34-0:ge 2270a, China cas:134861-34-0:ge 2270a manufacturers, suppliers, factory, 129954-34-3, CAS 129954 34 3, CAS 137525 51 0, CAS 1415456 99 3, CAS 910463 68 2, Selank

Send Inquiry